We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Increased Focus on Postapproval Trials Prompts Guidance
Increased Focus on Postapproval Trials Prompts Guidance
August 17, 2007
As part of increased agency attention to postapproval studies, sometimes required for product approval, the FDA has issued new guidance addressing the study reports that manufacturers must submit at regular intervals.